Elemental Impurities: Sources, identification, control strategies and analytical techniques MCQs With Answer

This set of MCQs focuses on Elemental Impurities — their sources, identification, control strategies and analytical techniques — tailored for M.Pharm students studying MPA 102T Advanced Pharmaceutical Analysis. The questions are designed to reinforce understanding of ICH Q3D concepts, risk-based assessment, permitted daily exposure (PDE) rationale, sampling and sample preparation, instrumental approaches (ICP-MS, ICP-OES, AAS), digestion methods, calibration and quality assurance, and practical control measures such as supplier qualification and cleaning validation. Each question emphasizes both regulatory expectations and laboratory practice so you can evaluate and apply strategies for reliable detection, quantification and mitigation of elemental impurities in pharmaceutical development and quality control.

Q1. What is the most accurate description of “elemental impurities” as defined in regulatory guidance?

• Organic moieties derived from excipient degradation
• Inorganic elements or metals that may be present as impurities in drug substances, excipients, or finished drug products
• Residual solvents from manufacturing
• Microbial contaminants in parenteral products

Correct Answer: Inorganic elements or metals that may be present as impurities in drug substances, excipients, or finished drug products

Q2. Which analytical technique is most suitable for multi-element trace-level determination of elemental impurities in pharmaceutical products?

• Flame atomic absorption spectroscopy (FAAS)
• UV-Vis spectrophotometry
• Inductively coupled plasma mass spectrometry (ICP-MS)
• High performance liquid chromatography (HPLC)

Correct Answer: Inductively coupled plasma mass spectrometry (ICP-MS)

Q3. For solid oral dosage forms, which sample preparation approach is generally preferred to release and quantify elemental impurities accurately?

• Direct solvent extraction with methanol
• Open-dish hot-plate acid digestion
• Closed-vessel microwave-assisted acid digestion using concentrated nitric acid (with optional hydrogen peroxide)
• Sonication in water followed by filtration

Correct Answer: Closed-vessel microwave-assisted acid digestion using concentrated nitric acid (with optional hydrogen peroxide)

Q4. Why does ICH Q3D set limits based on Permitted Daily Exposure (PDE) rather than a single concentration value in the drug substance?

• PDE is easier to measure in the laboratory than concentration
• PDE allows global harmonization of analytical methods
• Because PDE reflects daily patient exposure considering route of administration and toxicological thresholds
• PDE ignores route of exposure which simplifies calculations

Correct Answer: Because PDE reflects daily patient exposure considering route of administration and toxicological thresholds

Q5. Which ICH Q3D element classification describes elements of highest toxicological concern that generally require focused assessment and control?

• Class 3 — elements with low toxicity and no known sources in pharmaceuticals
• Class 2B — elements with limited sources and minor concern
• Class 1 — elements (e.g., As, Cd, Pb, Hg) with established toxicity and significant concern that require assessment
• Class 2A — elements that are only environmentally relevant

Correct Answer: Class 1 — elements (e.g., As, Cd, Pb, Hg) with established toxicity and significant concern that require assessment

Q6. What ICP‑MS hardware or operational approach is commonly used to reduce polyatomic spectral interferences?

• Use of higher sample flow rates without internal standards
• Collision/reaction cell (CRC) technology or Kinetic Energy Discrimination (KED) in ICP-MS to reduce polyatomic interferences
• Switching to flame ionization detection
• Performing only single-point calibration

Correct Answer: Collision/reaction cell (CRC) technology or Kinetic Energy Discrimination (KED) in ICP-MS to reduce polyatomic interferences

Q7. Which calibration or quantification strategy best compensates for strong matrix effects in elemental analysis by ICP-MS?

• External calibration with water-based standards only
• Internal standardization using isotopically similar internal standards or use of standard addition
• Use of single-point calibration without verification
• Blank subtraction of reagent water signal

Correct Answer: Internal standardization using isotopically similar internal standards or use of standard addition

Q8. How are LOD (limit of detection) and LOQ (limit of quantification) commonly defined in terms of signal-to-noise ratio?

• LOD = 1:1, LOQ = 2:1
• LOD = 3:1, LOQ = 10:1
• LOD = 10:1, LOQ = 100:1
• LOD = 0.1:1, LOQ = 0.5:1

Correct Answer: LOD = 3:1, LOQ = 10:1

Q9. Which quality assurance practice is essential to demonstrate accuracy of an elemental impurity method?

• Only running calibration standards at the start of a batch
• Use of spike recovery experiments and certified reference materials (CRMs) to verify method accuracy
• Relying solely on instrument factory settings
• Running blanks without matrix-matching

Correct Answer: Use of spike recovery experiments and certified reference materials (CRMs) to verify method accuracy

Q10. Which of the following is a plausible source of elemental impurities in a finished oral solid dosage form?

• Leaching from primary packaging components such as glass, metal closures or metal-contacting processing equipment
• Color changes due to oxidation of active ingredient
• Microbial contamination from raw water only
• Loss of volatile organic impurities during drying

Correct Answer: Leaching from primary packaging components such as glass, metal closures or metal-contacting processing equipment

Q11. What is the best practice for calibration when performing trace-level multi-element analysis by ICP-MS?

• Single-point calibration using a convenient mid-level concentration
• Multi-point calibration with certified multi-element standards combined with internal standard correction and ongoing calibration verification
• Calibrationless measurement based on instrument sensitivity only
• Using only vendor-supplied tune solution without matrix-matched standards

Correct Answer: Multi-point calibration with certified multi-element standards combined with internal standard correction and ongoing calibration verification

Q12. What common analytical problem can result from the presence of high chloride in digested samples analyzed by ICP-MS?

• Formation of volatile organics that foul the torch
• Production of polyatomic chloride-based interferences (e.g., ArCl+) that can overlap analyte masses
• Complete suppression of all element signals with no possible correction
• Enhanced ionization of all analytes leading to false high readings

Correct Answer: Production of polyatomic chloride-based interferences (e.g., ArCl+) that can overlap analyte masses

Q13. How does the traditional pharmacopeial “heavy metals” colorimetric test differ from the elemental impurities approach?

• The colorimetric test is element-specific and more sensitive than ICP-MS
• The colorimetric test gives a qualitative or semi-quantitative total metals result and lacks element-specific quantification, whereas elemental impurity testing uses element-specific instrumental methods (e.g., ICP-MS)
• Both methods are chemically identical but use different glassware
• The elemental impurities approach ignores regulatory limits

Correct Answer: The colorimetric test gives a qualitative or semi-quantitative total metals result and lacks element-specific quantification, whereas elemental impurity testing uses element-specific instrumental methods (e.g., ICP-MS)

Q14. Which actions form part of a robust control strategy to limit elemental impurities entering a drug product?

• Only monitoring final product without upstream controls
• Risk-based supplier qualification, raw material testing, cleaning validation, process controls and specification setting based on PDE
• Removing all metal-contacting equipment regardless of risk
• Relying solely on environmental air monitoring

Correct Answer: Risk-based supplier qualification, raw material testing, cleaning validation, process controls and specification setting based on PDE

Q15. Which reagent combination is most widely recommended for oxidative digestion of organic pharmaceutical matrices prior to elemental analysis?

• Hydrochloric acid alone in open beakers
• Dilute acetic acid and ethanol
• Concentrated nitric acid with hydrogen peroxide in closed-vessel microwave digestion
• Sodium hydroxide followed by neutralization

Correct Answer: Concentrated nitric acid with hydrogen peroxide in closed-vessel microwave digestion

Q16. Why is the standard addition method sometimes preferred for trace elemental analysis in complex pharmaceutical matrices?

• It shortens instrument run time dramatically
• It eliminates the need for digestion
• It compensates for sample matrix effects by spiking known amounts into the sample matrix itself
• It provides a substitute for certified reference materials

Correct Answer: It compensates for sample matrix effects by spiking known amounts into the sample matrix itself

Q17. When selecting an isotope for quantification in ICP‑MS, what is the principal consideration?

• Choose the isotope with the highest mass number irrespective of interference
• Select the isotope with the highest natural abundance and minimal isobaric or polyatomic interferences
• Always use only the most abundant isotope even if interfered
• Prefer isotopes that require no mass calibration

Correct Answer: Select the isotope with the highest natural abundance and minimal isobaric or polyatomic interferences

Q18. Which instrument generally provides the lowest practical detection limits for most trace elements in pharmaceutical samples?

• Graphite furnace atomic absorption (GFAAS)
• Inductively coupled plasma mass spectrometry (ICP-MS)
• Inductively coupled plasma optical emission spectroscopy (ICP-OES)
• Flame atomic absorption spectroscopy (FAAS)

Correct Answer: Inductively coupled plasma mass spectrometry (ICP-MS)

Q19. In the laboratory quality program, how does instrument qualification differ from method validation for elemental impurity testing?

• Qualification documents clinical suitability while validation tests packaging compatibility
• Qualification verifies instrument installation, operational and performance suitability; validation demonstrates that the analytical method meets defined performance characteristics (accuracy, precision, linearity, LOD/LOQ, specificity)
• They are identical processes with different names
• Qualification is optional and validation is never required

Correct Answer: Qualification verifies instrument installation, operational and performance suitability; validation demonstrates that the analytical method meets defined performance characteristics (accuracy, precision, linearity, LOD/LOQ, specificity)

Q20. When a finished drug product can receive elemental impurities from multiple sources (API, excipients, manufacturing equipment, and packaging), what is the correct regulatory approach to demonstrate compliance with PDEs?

• Only test the highest-risk raw material and ignore the rest
• Conduct a risk assessment, estimate and sum potential contributions from all sources, and compare the total expected daily intake to the PDE for the finished dose
• Assume worst-case contamination and set arbitrary low specifications without justification
• Rely only on environmental monitoring data to assess exposure

Correct Answer: Conduct a risk assessment, estimate and sum potential contributions from all sources, and compare the total expected daily intake to the PDE for the finished dose

Download